Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain‐DDR Study
Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1390-1397
DOI: 10.1111/apt.70543 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 28.01.2026. Verfasst von Ana Alberola und 59 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Clínico San Cecilio, Granada, Spain. Hauptthemen laut MEDLINE: Hepatitis D, Hepatitis Delta Virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Background
Hepatitis delta virus accelerates liver disease progression in chronic hepatitis B, yet remains underdiagnosed. Guidelines recommend double reflex diagnostic testing with antibody testing followed by viral load testing, but uptake remains inconsistent.
Aims
To evaluate double reflex diagnostic implementation in Spain during the retrospective phase of the Spain Double Reflex Diagnostic study.
Methods
Nationwide, multicenter retrospective analysis of individuals positive for hepatitis B surface antigen (2022–2024) from 80 centers. Laboratory data included hepatitis B surface antigen, hepatitis delta virus antibody and hepatitis delta virus viral load. Uptake rates, hepatitis delta virus antibody positivity, viral load confirmation and viral load‐confirmed prevalence were calculated with 95% confidence intervals.
Results
Among 65,763 individuals positive for hepatitis B surface antigen, hepatitis delta virus antibody testing uptake increased from 55.1% (54.4–55.8) in 2022 ( n = 18,986) to 72.5% (71.9–73.1) in 2023 ( n = 22,463) and 85.8% (85.1–86.4) in 2024 ( n = 24,314; p < 0.0001). Antibody positivity remained stable (5.6%, 4.9%, 5.3%). Viral load confirmation among antibody‐positive patients improved from 72.6% in 2022 to 90.8% in 2023 and 91.0% in 2024. Viral load‐confirmed prevalence among antibody‐positive individuals was 40.3% in 2022, 31.6% in 2023, and 30.1% in 2024. Regional heterogeneity was marked, with several autonomous communities achieving near‐universal uptake (> 95%).
Conclusion
Between 2022 and 2024, double reflex diagnostic implementation expanded rapidly, demonstrating national feasibility and describing hepatitis D virus seroprevalence. However, regional inequities persist. Sustained uptake will require standardised reflex protocols, harmonization of viral load assays and continuous training to reduce underdiagnosis and improve care of coinfected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Universitario Clínico San Cecilio, Granada, Spain.
- Instituto de Investigación Biosanitaria Ibs. Granada, Granada, Spain.
- Centro de Investigación Biomédica en Red Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
- Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
- Hospital Torrecárdenas, Almería, Spain.
- Hospital Universitario Puerto Real, Cádiz, Spain.
ORCID-Profile: Ana Alberola, Adolfo de Salazar, Francisco Javier Hernández-Felices, Jorge Camacho
Förderung
- Gilead Sciences
Zitieren
APA
Alberola, A., de Salazar, A., Fuentes, A., Carracedo, R., Illescas-López, M., Rodríguez Baños, M. D. C., Freyre, C., Becerril, B., Viciana, I., López-Rodríguez, I., Montiel, N., Domínguez Castaño, A. M., Luzón-García, M. P., Ramírez Arellano, E., Liébana-Martos, C., Franco Álvarez de Luna, F., Lozano, M. D. C., Palop, B., Sampedro, A., …, & García-de Cruz, S. (2026). Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain‐DDR Study. Alimentary Pharmacology & Therapeutics, 63(10), 1390-1397. https://doi.org/10.1111/apt.70543
Vancouver
Alberola A, de Salazar A, Fuentes A, Carracedo R, Illescas-López M, Rodríguez Baños MDC, et al. Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain‐DDR Study. Alimentary Pharmacology & Therapeutics. 2026;63(10):1390-1397. doi:10.1111/apt.70543
BibTeX
@article{Alberola2026,
author = {Alberola, Ana and de Salazar, Adolfo and Fuentes, Ana and Carracedo, Raquel and Illescas-López, Marta and Rodríguez Baños, María Del Carmen and Freyre, Carolina and Becerril, Berta and Viciana, Isabel and López-Rodríguez, Inmaculada and Montiel, Natalia and Domínguez Castaño, Ana María and Luzón-García, María Pilar and Ramírez Arellano, Encarnación and Liébana-Martos, Carmen and Franco Álvarez de Luna, Francisco and Lozano, María Del Carmen and Palop, Begoña and Sampedro, Antonio and Pérez, Ana Belén and Algarate, Sonia and Rojo Alba, Susana and Fraile, Pablo and Ocete, Dolores and Alcaraz, María Jesús and Rodríguez, Juan Carlos and Hernández-Felices, Francisco Javier and Martínez, Olalla and Domínguez, Victoria and Orta, Nieves and Gómez, Dolores and Cortell, Carmen and Camacho, Jorge and Sabater, Susana and Iglesias Sánchez, Luis Ángel and Martín, Yasmina and Vallejo, Aldara and Molina, Lourdes and Aroca, María and Castro, Beatriz and Lara, Magdalena and Pena, María José and Rodríguez-Fernández, Ana and González Praetorius, Alejandro and Blas, José Joaquín and Beteta, Alicia and Gómez, César and Rodríguez, María José and Illescas, Soledad and Abreu, Melanie and García Díez, Julio and Beltrán, Inocencio and Sandoval Torrientes, Marta and Sáez, Ruth and Martín, Teresa and Tajada Alegre, Pilar and Lorenzo, Belén and García Valero, María Teresa and Jiménez Sansegundo, Isabel and García-de Cruz, Susana},
title = {Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain‐DDR Study},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {10},
pages = {1390--1397},
doi = {10.1111/apt.70543}
}
EUVIMED